New AI model optimizes skin cancer treatments

Why we are writing on this topic:

AI is the future of healthcare and can dramatically improve patient care. Developments around AI follow one another quickly. To be aware of the latest inventions, Innovation Origins has selected this news.

Researchers from the University of Helsinki have developed a model of artificial intelligence. In practice, the AI ​​model makes it possible to diagnose skin cancer with a blood test, to determine its prognosis and to target therapies more and more precisely, writes the university in a press release.

The research project was carried out in cooperation with the HUS Comprehensive Cancer Center, Aalto University and Stanford University. Using the AI ​​model, the group analyzed samples from nearly 500 skin cancer patients and compared them to samples from nearly 1,000 healthy people. To aid interpretation, the researchers used another AI model developed by Stanford University. From these samples, the researchers simply calculated the number of immune cells that recognized skin cancer.

Results and new applications

As expected, more skin cancer-sensing defensive cells were found in patients with the disease than in healthy patients. Additionally, skin cancer patients who had more defensive cells that recognized skin cancer were more likely to benefit from therapies that activate the immune system than those who lacked such cells.

“Before this study, doctors were unable to predict who would benefit from a treatment that activates the defense system. Correct targeting of therapies is extremely important because drug therapies are expensive and serious adverse effects are quite common,” concludes Dr Jani Huuhtanen from the University of Helsinki and Aalto University. The researchers will now investigate whether the AI ​​model also works for other types of cancer.